Literature DB >> 13701987

Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).

A P FRIEDMAN, S LOSIN.   

Abstract

Entities:  

Keywords:  LYSERGIC ACID DIETHYLAMIDE/related compounds; MIGRAINE/therapy

Mesh:

Substances:

Year:  1961        PMID: 13701987     DOI: 10.1001/archneur.1961.00450090007002

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  9 in total

1.  CLINICAL TRIAL OF METHYSERGIDE AND OTHER PREPARATIONS IN THE MANAGEMENT OF MIGRAINE.

Authors:  D A CURRAN; J W LANCE
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-10       Impact factor: 10.154

2.  METHYSERGIDE FOR MIGRAINE.

Authors: 
Journal:  Br Med J       Date:  1964-05-23

3.  Migraine in a rural practice (1958-1963). A five-year study of a controlled clinical trial.

Authors:  C Burns
Journal:  J Coll Gen Pract       Date:  1965-11

4.  Methysergide in prophylaxis of migraine: a clinical trial in general practice.

Authors:  J Whewell
Journal:  Br Med J       Date:  1966-08-13

5.  Cluster migraine--an unrecognized common entity.

Authors:  R F Nelson
Journal:  Can Med Assoc J       Date:  1970-11-07       Impact factor: 8.262

6.  Prophylaxis of recurrent headache.

Authors: 
Journal:  Br Med J       Date:  1969-01-04

7.  Research in migraine.

Authors: 
Journal:  Br Med J       Date:  1966-05-28

Review 8.  Management of trigeminal autonomic cephalgias and hemicrania continua.

Authors:  Manjit S Matharu; Christopher J Boes; Peter J Goadsby
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  METHYSERGIDE (SANSERT) IN THE PREVENTION OF MIGRAINE: A CLINICAL TRIAL.

Authors:  D L LLOYD-SMITH; F L MCNAUGHTON
Journal:  Can Med Assoc J       Date:  1963-12-14       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.